Quantcast

Latest Management of cancer Stories

2014-04-08 12:32:28

Champions TumorGrafts(TM) Provide Accurate Predictions of Treatments' Efficacy in 81 Percent of Evaluated Patients with Advanced Sarcoma HACKENSACK, N.J., April 8, 2014 /PRNewswire/ -- Data published in Cancer show the use of personalized patient-derived xenografts, or mouse avatars, accurately predicted treatment efficacy in all evaluated patients with advanced sarcoma. The results support the predictive capabilities of Champions TumorGrafts®, developed by Champions Oncology (OTC:...

2014-04-08 08:30:56

Creative innovator to advance Epic's CTC technology for rapid analysis of cancer for patient matching to clinical trials, therapeutic selection and resistance monitoring SAN DIEGO, April 8, 2014 /PRNewswire/ -- Epic Sciences announced today the appointment of Pascal Bamford, Ph.D. as vice president of product development. Dr. Bamford has more than 15 years of experience in developing complex, automated diagnostic systems for digital pathology. Prior to joining Epic Sciences, Dr....

2014-04-07 16:35:29

Women who have radiotherapy for breast cancer have a small but significantly increased risk of subsequently developing a primary lung tumour, and now research has shown that this risk increases with the amount of radiation absorbed by the tissue. Dr Trine Grantzau (MD) told the 33rd conference of the European Society for Radiotherapy and Oncology (ESTRO33) in Vienna: "We found that for each Gray delivered to the lung as part of radiotherapy for a breast tumour, the relative risk of...

2014-04-07 08:29:57

PRINCETON, N.J., April 7, 2014 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today that the National Institute of Dental and Craniofacial Research (NIDCR) has awarded Soligenix a Small Business Innovation Research (SBIR) grant...

2014-04-04 23:22:41

Researchers in Italy say their review of studies on the link between selenium and malignancies like bladder cancer turned up too little evidence to support supplementation. Raleigh, NC (PRWEB) April 04, 2014 Italian scientists say patients fighting bladder cancer and other types of cancer are not likely to get any benefit from the metalloid nutritional supplement, selenium. The new meta-analysis has just been posted on the Cancer Monthly website and can be read by clicking here....

2014-04-04 12:35:32

Using magnetically controlled nanoparticles to force tumor cells to 'self-destruct' sounds like science fiction, but could be a future part of cancer treatment, according to research from Lund University in Sweden. "The clever thing about the technique is that we can target selected cells without harming surrounding tissue. There are many ways to kill cells, but this method is contained and remote-controlled", said Professor Erik Renström. The point of the new technique is that it is...

2014-04-02 23:27:09

A new UK report on the early warning signs of bladder cancer is especially relevant for diabetics and those who have taken Actos. Raleigh, NC (PRWEB) April 02, 2014 A newly published report prepared by a team of medical oncologists in the UK says early recognition of bladder cancer symptoms could be the difference between life and death. A new article on the report has just been posted on the Cancer Monthly website and can be read by clicking here. Drs. Karen DeSouza, Simon Chowdhury and...

2014-04-02 08:33:15

Clinicians at Humanitas Cancer Center in Milan among first in world to commence treatments using Edge radiosurgery system MILAN, Italy, April 2, 2014 /PRNewswire/ -- Humanitas Cancer Center in Milan has become one of the first hospitals in the world to commence cancer treatments using the new Edge(TM) radiosurgery system from Varian Medical Systems (NYSE: VAR). This precise, non-invasive alternative to conventional surgery has been used to treat several patients with lung, prostate,...

2014-04-01 20:21:49

DUBLIN, April 2, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/pttfr4/cancer_gene) has announced the addition of the "Cancer Gene Therapy Market Analysis" [http://www.researchandmarkets.com/research/pttfr4/cancer_gene ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The gene therapy market has undergone series of transformation from the initial days of research to current clinical...

2014-03-31 20:22:11

DUBLIN, April 1, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/fl4bmp/global_cell) has announced the addition of the "Global Cell Therapy Market & Pipeline Insight" [http://www.researchandmarkets.com/research/fl4bmp/global_cell ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Research in cell therapy is transforming the future of medicine. As the life of a human being begins as...


Word of the Day
mundungus
  • A stinking tobacco.
  • Offal; waste animal product; organic matter unfit for consumption.
This word comes from the Spanish 'mondongo,' tripe, entrails.